Presentation:
Advances in unbiased next-generation sequencing methods for characterizing all RNA transcripts in a sample have revolutionized scientific research in the past decade, leading to discoveries related to how variation in people impacts responses to disease outcomes, vaccination and therapeutics. Transcriptomics assays expression from every gene in an organism’s genome to reveal the global pattern of transcription. Measuring gene expression in different tissues, conditions, or at different times can reveal details of an organism’s biology that result in differential disease outcomes. Transcriptomics was first developed as bulk RNA sequencing (RNA-seq), which yields an aggregate of all gene expression in many cells. Recent single cell RNA-seq (scRNA-seq) techniques provide transcriptomics data for individual cells, which delineate changes in each cell relative to another. This talk describes how we used scRNA-seq to measure not only the host transcripts, but also HIV RNA (vRNA) expression in people living with HIV during acute HIV-1 infection (AHI). This method allowed us to identify host factors restricting HIV-1 transcripts in vivo without any additional laboratory manipulation. A subset of CD4+ T cells with a memory phenotype had the most vRNA+ cells, recapitulating previous data using other methods. Frequency of these cells correlated with important clinical parameters like plasma viremia and cell-associated HIV DNA levels, suggesting that the identified vRNA+ cells were biologically meaningful. When analyzing viral transcripts as a continuous phenotype across individual cells, we identified several host genes for which higher expression levels associated with lower vRNA. PTMA showed the strongest association with lower vRNA expression. This observation was validated in additional participants from different world populations and HIV subtypes. PTMA expression at timepoints after initiation of treatment showed an inverse correlation with frequency of vRNA+ cell measured during AHI, suggesting that changes in PTMA even in the absence of viremia can affect viral transcript levels. In vitro overexpression experiments provided direct evidence that expression of the prothymosin α protein encoded by PTMA inhibited HIV-1 transcription and expression. These results identify prothymosin α as a host factor that restricts HIV-1 infection in vivo, which has implications for viral transmission and cure strategies.